Valuation: Abbott Laboratories

Market Cap 18TCr 15TCr 14TCr 13TCr 25TCr 16,99500Cr 25TCr 1,71500Cr 67TCr 8,28900Cr 66TCr 64TCr 28,75800Cr P/E 2026 *
28.6x
P/E 2027 * 22.2x
Enterprise Value 20TCr 17TCr 16TCr 15TCr 28TCr 19,25900Cr 29TCr 1,94300Cr 76TCr 9,39400Cr 75TCr 73TCr 32,58900Cr EV / Sales 2026 *
3.95x
EV / Sales 2027 * 3.5x
Free-Float
86.73%
Yield 2026 *
2.57%
Yield 2027 * 2.7%
1 day+0.29%
1 week+1.94%
Current month+11.03%
1 month+11.29%
3 months+8.94%
6 months-6.21%
Current year-19.59%
1 week 99.34
Extreme 99.34
102.46
1 month 87.64
Extreme 87.64
102.46
Current year 81.97
Extreme 81.97
129.46
1 year 81.97
Extreme 81.97
137.49
3 years 81.97
Extreme 81.97
141.23
5 years 81.97
Extreme 81.97
142.6
10 years 37.38
Extreme 37.38
142.6
Manager TitleAgeSince
Chief Executive Officer 52 31/03/2020
Director of Finance/CFO 53 01/09/2023
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 09/12/2011
Director/Board Member 67 09/12/2011
Director/Board Member 71 16/02/2017
Date Insider Type Main position Quantity % Market Cap.
30/06/26 Free

Director

432 0.0000%
30/06/26 Free

Director

231 0.0000%
30/06/26 Free

Director

416 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
+0.18%+1.94%-19.93%-11.85% 18TCr
+0.15%-1.85%-10.87%-7.81% 10TCr
+1.49%-0.95%+3.96%+58.40% 5.94TCr
-1.13%-2.60%+26.37%+54.76% 5.07TCr
-0.12%-4.35%-16.22%-42.24% 4.21TCr
+1.21%-8.47% - - 3.18TCr
-1.33%-9.62%-18.45%-46.03% 2.72TCr
-0.82%-1.92%+56.39%-5.79% 2.51TCr
+0.03%-4.74%-6.58%-9.24% 2.05TCr
+0.30%-4.54%-16.61%-2.81% 1.94TCr
Average +0.01%-3.30%-0.22%-1.40% 5.57TCr
Weighted average by Cap. +0.15%-1.54%-6.27%-0.15%

Financials

2026 *2027 *
Net sales 5.03TCr 4.42TCr 4.11TCr 3.78TCr 7.09TCr 4,87000Cr 7.21TCr 49TCr 19TCr 2,37500Cr 19TCr 18TCr 8,24100Cr 5.46TCr 4.8TCr 4.46TCr 4.11TCr 7.7TCr 5,29000Cr 7.84TCr 53TCr 21TCr 2,58000Cr 21TCr 20TCr 8,95200Cr
Net income 631.95Cr 555.8Cr 516.33Cr 474.89Cr 890.57Cr 61TCr 906.53Cr 6.17TCr 2.41TCr 30TCr 2.37TCr 2.32TCr 1,03600Cr 794.45Cr 698.72Cr 649.1Cr 596.99Cr 1.12TCr 77TCr 1.14TCr 7.76TCr 3.03TCr 38TCr 2.98TCr 2.92TCr 1,30200Cr
Net Debt 2.34TCr 2.06TCr 1.91TCr 1.76TCr 3.3TCr 2,26400Cr 3.35TCr 23TCr 8.91TCr 1,10400Cr 8.78TCr 8.59TCr 3,83200Cr 1.57TCr 1.38TCr 1.29TCr 1.18TCr 2.22TCr 1,52500Cr 2.26TCr 15TCr 6TCr 74TCr 5.91TCr 5.78TCr 2,58000Cr
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
1,15,000
Date Price Change Volume
23/26/23 $100.75 +0.18% 99,59,504
22/26/22 $100.57 +0.90% 1,02,57,524
21/26/21 $99.67 -1.96% 1,16,56,451
20/26/20 $101.66 +0.97% 1,43,90,641
17/26/17 $100.68 +1.87% 1,99,13,777
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
100.75USD
Average target price
119.12USD
Spread / Average Target
+18.24%

Quarterly revenue - Rate of surprise